share_log

Roth MKM Initiates Coverage On Tenax Therapeutics With Buy Rating, Announces Price Target of $6

Benzinga ·  Mar 7, 2023 04:09

Roth MKM analyst Jonathan Aschoff initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Buy rating and announces Price Target of $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment